At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
01873 VIVA BIOTECH
Market Closed 10-16 16:08:16
1.370
+0.045
+3.40%
High1.415
Low1.320
Vol4.68M
Open1.375
D1 Closing1.325
Amplitude7.17%
Mkt Cap2.87B
Tradable Cap2.87B
Total Shares2.09B
T/O6.39M
T/O Rate0.22%
Tradable Shares2.09B
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Sealand Securities Initiates Buy Rating on VIVA BIOTECH, Citing AIDD-Enabled Structural Drug Screening
VIVA Biotech Holdings is an investment holding company. The Company has two segments. The Drug Discovery Services segment provides structure-based drug discovery services to biotech and pharmaceutical clients for preclinical innovative drug development. The Contract Design and Manufacturing (CDMO) and Commercialization Services segment is engaged in contract development and manufacturing services for small molecule Active Pharmaceutical Ingredients (APIs) and intermediates, as well as the trading of APIs, intermediates and finished products. The Company conducts business primarily in the United States, China, Europe and other regions.